Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
46,122,563
-
Share change
-
-1,480,588
-
Total reported value
-
$4,442,511,426
-
Put/Call ratio
-
17%
-
Price per share
-
$96.32
-
Number of holders
-
127
-
Value change
-
-$194,325,083
-
Number of buys
-
68
-
Number of sells
-
60
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q3 2019
As of 30 Sep 2019,
Ascendis Pharma A/S - ADR (ASND) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,122,563 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, Artisan Partners Limited Partnership, Avoro Capital Advisors LLC, EVENTIDE ASSET MANAGEMENT, LLC, FARALLON CAPITAL MANAGEMENT LLC, and WESTFIELD CAPITAL MANAGEMENT CO LP.
This page lists
127
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.